EX-FILING FEES 7 d389734dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form F-4

(Form Type)

Oculis Holding AG

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
     Security  
Type  		  

Security

Class Title

   Fee
Calculation
Rule		   Amount
Registered(1) 		  Proposed
Maximum
Offering
Price Per
Unit		   Maximum Aggregate
Offering Price		   Fee Rate   Amount of
Registration
Fee
 
Newly Registered Securities
                 
Fees to Be Paid   Equity    Ordinary Shares(2)  

457(f)(1)

  

44,524,604 

  

$9.99(3)

  

$444,800,794.00 

  

$110.20 per

$1,000,000.00(4)

  

$49,017.05

                 
Fees Previously Paid   Equity    Ordinary Shares(7)  

457(f)(1)

  

44,596,718 

  

$9.99(3)

  

$445,521,223.00 

  

$110.20 per

$1,000,000.00(4)

  

$49,096.44

                 
Fees to Be Paid   Other   

Warrants to purchase

Ordinary Shares

  

—

  

— 

   —   —   —   —
                 
Fees Previously Paid   Other   

Warrants to purchase

Ordinary Shares(5)

  

457(g)

  

4,403,294 

   —   —   —   —(6)
 
Carry Forward Securities
                 
Carry Forward Securities   —   —   —   —    —   —   —   —
           
    Total Offering Amounts   —   —   —   $49,017.05
           
    Total Fees Previously Paid   —   —   —   $49,096.44
           
    Total Fee Offsets   —   —   —   —
           
    Net Fee Due(8)   —   —   —   $(79.39)

 

(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.

(2)

The number of shares of ordinary shares, par value CHF 0.01 per share, of New Parent (as defined in the accompanying proxy statement/prospectus) (the “New Parent Shares”) to be issued in respect of (i) 13,209,880 Class A ordinary shares, par value $0.0001 per share, underlying units issued in European Biotech Acquisition Corp.’s (“EBAC”) initial public offering (“EBAC Class A Common Stock”) issued and outstanding immediately prior to the First Merger (as defined in the accompanying proxy statement/prospectus), which shall convert into an equal number of New Parent Shares in connection with the proposed transaction described in the accompanying proxy statement/prospectus, (ii) 20,276,208 Class B ordinary shares, par value $0.0001 per share, of EBAC issued and outstanding immediately prior to the First Merger held by LSP Sponsor EBAC B.V. LLC (the “Sponsor”), which shall convert into an equal number of New Parent Shares in connection with the proposed transaction described in the accompanying proxy statement/prospectus, (iii) 20,348,322 New Parent Shares to be issued to Oculis Shareholders (as defined in the accompanying proxy statement/prospectus) in connection with the proposed transaction described in the accompanying proxy

  statement/prospectus, (iv) 745,540 vested options to purchase shares of Oculis common stock as described in the accompanying proxy statement/prospectus) as of immediately prior to the Acquisition Closing (as defined in the accompanying proxy statement/prospectus), which will automatically be “net exercised” in full as of the Acquisition Closing and be converted into 173,622 New Parent Shares determined in accordance with the exchange ratio as set forth in the Business Combination Agreement, (v) 3,819,998 New Parent Shares to be issued to certain Oculis Shareholders at the Acquisition Closing in connection with the Earnout Consideration (as defined in the accompanying proxy statement/prospectus), earned upon the achievement of certain trading price targets of the Registrant’s New Parent Shares described in the accompanying proxy statement/prospectus, (vi) 180,002 New Parent Shares in respect of the Earnout Options (as defined in the accompanying proxy statement/prospectus), which Earnout Options are to be issued to certain Oculis Shareholders at the Acquisition Closing described in the accompanying proxy statement/prospectus and (vii) 4,403,294 New Parent Shares issuable upon the exercise of New Parent Warrants. Each such warrant is exercisable for one New Parent Share at a price of $11.50 per share, subject to adjustment.
(3)

Estimated solely for the purpose of calculating the registration fee, based upon the average of the high and low prices of EBAC Class A Common Stock on the Nasdaq Capital Market on November 3, 2022 ($9.99 per share of EBAC Class A Common Stock).

(4)

Pursuant to Section 6(b) of the Securities Act, a rate equal to $110.20 per $1,000,000 of the proposed maximum aggregate offering price.

(5)

The number of New Parent Warrants to purchase New Parent Shares being registered represents (i) 4,251,595 warrants to purchase one share of EBAC Class A Common Stock underlying the units issued in EBAC’s initial public offering and (ii) 151,699 warrants to purchase one share of EBAC Class A Common Stock issued to the Sponsor in a private placement simultaneously with the closing of EBAC’s initial public offering.

(6)

No fee pursuant to Rule 457(g) of the Securities Act.

(7)

Reflects the previously stated amount of 20,348,322 New Parent Shares to be issued to Oculis Shareholders (as defined in the accompanying proxy statement/prospectus) in connection with the proposed transaction described in the accompanying proxy statement/prospectus. As described in note (2) above, the amount for this offering has now decreased to a new total of 20,276,208 of such New Parent Shares.

(8)

Please note that the Registrant previously paid a fee of $49,096.44 for a transaction with the Maximum Aggregate Offering Price of $445,521,223. The revised Maximum Aggregate Offering Price is $444,800,794, or $79.39 less. Therefore, the Registrant has overpaid the filing fees for the current transaction by $79.39.

Table 2: Fee Offset Claims and Sources

 

                       
     Registrant
or Filer
Name		   Form or
Filing
Type		   File
Number		   Initial  
Filing  
Date  		   Filing  
Date  		   Fee
Offset
Claimed		   Security
Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		   Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		   Fee Paid
with Fee
Offset
Source
 
Rules 457(b) and 0-11(a)(2)
                       
Fee Offset Claims     —     —     —       —              
                       
Fee Offset Sources   —     —     —       —               —
 
Rule 457(p)
                       
Fee Offset Claims   —     —     —     —     —     —       —       —       —        
                       
Fee Offset Sources   —     —     —         —                         —

Table 3: Combined Prospectuses

 

             
Security Type   Security Class Title    Amount of Securities 
Previously Registered 		   Maximum Aggregate 
Offering Price of Securities 
Previously Registered 		   Form   
Type   		   File  
Number  		   Initial Effective 
Date 
             
—   —   —   —   —   —   —